Begin typing your search above and press return to search.
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
access_time 16 Aug 2023 5:46 AM GMT
May that spark not be extinguished
access_time 2 Dec 2023 8:55 AM GMT
A Constitution always in the making
access_time 27 Nov 2023 11:43 AM GMT
Debunking myth of Israel’s existence
access_time 23 Oct 2023 7:01 AM GMT
Homechevron_rightLifestylechevron_rightHealthchevron_rightSouth Africa stops...

South Africa stops rollout of Johnson and Johnson vaccine over blood clot fears

South Africa stops rollout of Johnson and Johnson vaccine over blood clot fears

South African Health Minister Zweli Mkhize announced in a press conference on Tuesday that South Africa would be joining the United States in pausing the rollout of the Johnson and Johnson vaccine amidst reports that 6 recipients of the vaccine had developed blood clots with low platelet counts.

"After this advisory came to my attention, I held urgent consultations with our scientists, who have advised that we cannot take the decision made by the US Food and Drug Administration (FDA) lightly," the minister said. "Based on their advice, we have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson and Johnson vaccine is sufficiently interrogated."

However, the minister also cautioned against panic as the cases of blood clots had all come from the US and there had been none reported in South Africa so far despite the J&J vaccine having been administered to over 200,000 health workers. He assured the public that the government would cooperate with Johnson and Johnson as well as the FDA in investigating and understanding the situation.

"Given the preliminary literature on hand, our scientists are confident that the FDA''s decision is on a precautionary basis and we expect that this will not result in the complete withdrawal of the Johnson and Johnson vaccine from the vaccination armament," he said.

South Africa has lost 53,498 lives to COVID-19 so far, along with 1,561,559 confirmed cases in the country, according to Johns Hopkins University. The Johnson and Johnson vaccine was approved for use after it showed promising results against the new and more virulent strain of the COVID-19 virus that arose in the country.

Show Full Article
TAGS:Johnson& JohnsonSouth Africablood clot
Next Story